EUPHROSYNE LIMITED

Company Registration Number:
07391060 (England and Wales)

Unaudited micro entity accounts for the year ended 11 May 2025

Period of accounts

Start date: 01 October 2024

End date: 11 May 2025

EUPHROSYNE LIMITED

Contents of the Financial Statements

for the Period Ended 11 May 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

EUPHROSYNE LIMITED

Company Information

for the Period Ended 11 May 2025




Director: Alan Geoffrey Wainwright
Kwi Ma Wainwright
Registered office: The Vicarage
Dingestow
Monmouth
GB-WLS
NP25 4DY
Company Registration Number: 07391060 (England and Wales)

EUPHROSYNE LIMITED

Balance sheet

As at 11 May 2025

7 months to
11 May 2025
£

2024
£
Called up share capital not paid: 0 0
Fixed Assets: 100 183
Current assets: 103,172 211,771
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 102,768 ) ( 171,258 )
Net current assets (liabilities): 404 40,513
Total assets less current liabilities: 504 40,696
Creditors: amounts falling due after more than one year: ( 0 ) ( 40,389 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 0 ) ( 0 )
Total net assets (liabilities): 504 307
Capital and reserves: 504 307

EUPHROSYNE LIMITED

Balance sheet continued

For the year ending 11 May 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 3 September 2025
And Signed On Behalf Of The Board By:

Name: Alan Geoffrey Wainwright
Status: Director

The notes form part of these financial statements

EUPHROSYNE LIMITED

Footnotes to the Financial Statements

for the Period Ended 11 May 2025

  • 1. Employee Information

    Average number of employees: 2

EUPHROSYNE LIMITED

Footnotes to the Financial Statements

for the Period Ended 11 May 2025

  • 2. Off balance sheet disclosure

    No